Clinical variability of CMS-EA (congenital myasthenic syndrome with episodic apnea) due to identical CHAT mutations in two infants

被引:27
作者
Barisic, N
Müller, JS
Paucic-Kirincic, E
Gazdik, M
Lah-Tomulic, K
Pertl, A
Sertic, J
Zurak, N
Lochmüller, H
Abicht, A
机构
[1] Univ Zagreb, Sch Med, Dept Pediat, Zagreb 41000, Croatia
[2] Univ Munich, Friedrich Baur Inst, Dept Neurol, Munich, Germany
[3] Univ Munich, Friedrich Baur Inst, Gene Ctr, Munich, Germany
[4] Childrens Hosp Kantrida, Dept Pediat, Rijeka, Croatia
[5] Clin Med Ctr Zagreb, Genet Lab, Zagreb, Croatia
[6] Univ Zagreb, Sch Med, Dept Neurol, Zagreb 41000, Croatia
关键词
Congenital myasthenic syndrome; Episodic apnea; CHAT mutation; Chotine acetyltransferase (ChAT);
D O I
10.1016/j.ejpn.2004.10.008
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Congenital myasthenic syndromes (CMS) result from mutations in various synapse-associated genes. Mutations in the choline acetyltransferase (CHAT) gene cause a presynaptic CMS associated with episodic apnea (CMS-EA). We present two unrelated Croatian children affected by CMS-EA. Beside other clinical findings characteristic for CMS, both patients manifested intermittent apneas since early infancy. Whereas the course of disease is mild in the female patient (patient 2), the mate patient (patient 1) experienced recurrent and severe episodes of apnea despite adequate treatment with AChE-inhibitors and shows a global developmental delay with delayed myelination and signs of hypoxic-ischemic injury in brain imaging. Interestingly, sequencing of the CHAT gene revealed identical, compound heterozygous mutations S694C and T354M in both children. These findings are in Line with a remarkable clinical heterogeneity observed in patients with CHAT mutations and emphasize the potential role of apneic crises for the development of secondary hypoxic brain damage and psychomotor retardation. (C) 2004 European Paediatric Neurology Society. Published by Elsevier Ltd. ALL rights reserved.
引用
收藏
页码:7 / 12
页数:6
相关论文
共 20 条
  • [1] COORDINATED UP-REGULATION OF CHOLINE-ACETYLTRANSFERASE AND VESICULAR ACETYLCHOLINE TRANSPORTER GENE-EXPRESSION BY THE RETINOIC ACID RECEPTOR-ALPHA, CAMP, AND LEUKEMIA INHIBITORY FACTOR CILIARY NEUROTROPHIC FACTOR SIGNALING PATHWAYS IN A MURINE SEPTAL CELL-LINE
    BERSE, B
    BLUSZTAJN, JK
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (38) : 22101 - 22104
  • [2] Aberrant Patterning of neuromuscular synapses in choline acetyltransferase-deficient mice
    Brandon, EP
    Lin, WC
    D'Amour, KA
    Pizzo, DP
    Dominguez, B
    Sugiura, Y
    Thode, S
    Ko, CP
    Thal, LJ
    Gage, FH
    Lee, KF
    [J]. JOURNAL OF NEUROSCIENCE, 2003, 23 (02) : 539 - 549
  • [3] Congenital myasthenic syndrome associated with episodic apnea and sudden infant death
    Byring, RF
    Pihko, H
    Tsujino, A
    Shen, XM
    Gustafsson, B
    Hackman, P
    Ohno, K
    Engel, AG
    Udd, B
    [J]. NEUROMUSCULAR DISORDERS, 2002, 12 (06) : 548 - 553
  • [4] Choline acetyltransferase structure reveals distribution of mutations that cause motor disorders
    Cai, YY
    Cronin, CN
    Engel, AG
    Ohno, K
    Hersh, LB
    Rodgers, DW
    [J]. EMBO JOURNAL, 2004, 23 (10) : 2047 - 2058
  • [5] Mutation in the human acetylcholinesterase-associated collagen gene, COLQ, is responsible for congenital myasthenic syndrome with end-plate acetylcholinesterase deficiency (type Ic)
    Donger, C
    Krejci, E
    Serradell, AP
    Eymard, B
    Bon, S
    Nicole, S
    Chateau, D
    Gary, F
    Fardeau, M
    Massoulié, J
    Guicheney, P
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 63 (04) : 967 - 975
  • [6] Eiden LE, 1998, J NEUROCHEM, V70, P2227
  • [7] Sleuthing molecular targets for neurological diseases at the neuromuscular junction
    Engel, AG
    Ohno, K
    Sine, SM
    [J]. NATURE REVIEWS NEUROSCIENCE, 2003, 4 (05) : 339 - 352
  • [8] Congenital myasthenic syndromes: Progress over the past decade
    Engel, AG
    Ohno, K
    Sine, SM
    [J]. MUSCLE & NERVE, 2003, 27 (01) : 4 - 25
  • [9] Engel AG, 1994, MYOLOGY, P1798
  • [10] BRIEF PRESENTATION OF THE STORY AND PRESENT STATUS OF STUDIES OF THE VERTEBRATE CHOLINERGIC SYSTEM
    KARCZMAR, AG
    [J]. NEUROPSYCHOPHARMACOLOGY, 1993, 9 (03) : 181 - 199